Peter Verhamme
Impact in
- Internal Medicine top 0.02%
- Venous Thromboembolism Diagnosis and Management
-
- Atrial Fibrillation Management and Outcomes
- Antiplatelet Therapy and Cardiovascular Diseases
- Cardiac Arrhythmias and Treatments
Papers in
-
- Atrial Fibrillation Management and Outcomes 72
- Cardiovascular Health and Disease Prevention 19
- Antiplatelet Therapy and Cardiovascular Diseases 18
-
- Venous Thromboembolism Diagnosis and Management 92
- Co-authors
- Jeffrey I. Weitz (30 shared papers)Thomas Vanassche (99 shared papers)Peter Sinnaeve (10 shared papers)Hein Heidbüchel (9 shared papers)Matthias Antz (5 shared papers)Jonas Oldgren (5 shared papers)Marc Hoylaerts (33 shared papers)Werner Hacke (5 shared papers)
- Journals
- Journal of Thrombosis and Haemostasis (32 papers)Thrombosis Research (20 papers)European Heart Journal (14 papers)Blood (13 papers)Thrombosis and Haemostasis (13 papers)
- Partner nations
- BelgiumNetherlandsUnited States
In The Last Decade
Peter Verhamme
338 papers receiving 13.2k citations
Peter Verhamme's Hit Papers
Peers
Comparison fields: 5 of 157
- Internal Medicine 4.6k
- Cardiology and Cardiovascular Medicine 5.7k
- Hematology 1.4k
- Emergency Medical Services 479
- Genetics 687
Countries citing papers authored by Peter Verhamme
This map shows the geographic impact of Peter Verhamme's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Verhamme with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Verhamme more than expected).
Fields of papers citing papers by Peter Verhamme
This network shows the impact of papers produced by Peter Verhamme. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Verhamme. The network helps show where Peter Verhamme may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Verhamme, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 355 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism Hit paper breakdown → | 2017 | 1090 |
| 2 | Idarucizumab for Dabigatran Reversal Hit paper breakdown → | 2015 | 986 |
| 3 | Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation Hit paper breakdown → | 2015 | 747 |
| 4 | European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation Hit paper breakdown → | 2013 | 573 |
| 5 | Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism Hit paper breakdown → | 2017 | 509 |
| 6 | Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis Hit paper breakdown → | 2014 | 465 |
| 7 | 2001 | 413 | |
| 8 | Outpatient versus inpatient treatment for patients with acute pulmonary embolism: an international, open-label, randomised, non-inferiority trial Hit paper breakdown → | 2011 | 409 |
| 9 | Major Adverse Limb Events and Mortality in Patients With Peripheral Artery Disease Hit paper breakdown → | 2018 | 292 |
| 10 | 2013 | 276 | |
| 11 | Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians Hit paper breakdown → | 2017 | 265 |
| 12 | 2015 | 260 | |
| 13 | Abelacimab for Prevention of Venous Thromboembolism Hit paper breakdown → | 2021 | 192 |
| 14 | 2016 | 191 | |
| 15 | 2003 | 147 | |
| 16 | 2003 | 127 | |
| 17 | 2004 | 109 | |
| 18 | 2019 | 108 | |
| 19 | 2006 | 104 | |
| 20 | 2017 | 96 |
About Peter Verhamme
Peter Verhamme is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine, Surgery, Hematology and Infectious Diseases, having authored 355 papers that have together received 13.5k indexed citations. Recurring topics across this work include Venous Thromboembolism Diagnosis and Management (92 papers), Atrial Fibrillation Management and Outcomes (72 papers), Blood Coagulation and Thrombosis Mechanisms (20 papers), Cardiovascular Health and Disease Prevention (19 papers), Antiplatelet Therapy and Cardiovascular Diseases (18 papers), Antimicrobial Resistance in Staphylococcus (17 papers), Platelet Disorders and Treatments (15 papers) and Vitamin K Research Studies (14 papers). The work is most often cited by research in Internal Medicine (4.6k citations), Cardiology and Cardiovascular Medicine (5.7k citations), Hematology (1.4k citations), Emergency Medical Services (479 citations) and Genetics (687 citations). Peter Verhamme has collaborated with scholars based in Belgium, Netherlands and United States. Frequent co-authors include Jeffrey I. Weitz, Thomas Vanassche, Peter Sinnaeve, Hein Heidbüchel, Matthias Antz, Jonas Oldgren, Marc Hoylaerts, Werner Hacke, Marco Alings and Paulus Kirchhof. Their work appears in journals such as Journal of Thrombosis and Haemostasis, Thrombosis Research, European Heart Journal, Blood and Thrombosis and Haemostasis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.